After vocal opposition to his decision to join much-criticized CellTex Therapeutics, bioethicist Glenn McGee resigned from the stem cell company on February 28, reported Nature.

Three months ago, McGee took the position of president of ethics and strategic initiatives at CellTex. The move incited a backlash within the bioethics community, with critics voicing concerns regarding conflicts of interest stemming from McGee’s continued role as editor at the American Journal of Bioethics. McGee had described his move as an attempt to bring ethical standards to CellTex, which has been criticized for banking patients’ stem cells for unapproved and unproven therapies.

McGee announced his resignation via Twitter yesterday (February 29), saying “I am preparing timely, lengthy, pointed comments on the whole matter.”

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?